Copyright © 2024 Springer Healthcare Limited. Part of the Springer Nature Group.
CH_EM-115759
Many thanks to everyone, who attended the hybrid ASCO Direct™ GU Highlights Meeting on Friday, February 2, 2024.
The ASCO Direct™ GU Highlights Meeting was an educational program containing selected original sessions from the 2024 ASCO Genitourinary Cancers Symposium on prostate, renal cell and urothelial cancer. Attendees had the opportunity to view the original sessions and discuss the clinical relevance and implications for Swiss treatment landscape of study outcomes with their colleagues.
Here are the program and details of the ASCO Direct™ GU Highlights Meeting 2024. We look forward to organizing the ASCO Direct™ GU Highlights meeting 2025. The related information will be available later this year.
If you would like any further information, please feel free to contact us at asco@springer.com
Prof. Dr. med. Jörg Beyer and PD Dr. med. Aurelius Omlin
The on-demand recordings are no longer available.
The program is supervised by an independent scientific committee:
GU Cancer Experts:
Friday, February 2, 2024, from 14:30 until 19:30
The meeting is CME accredited for the live participation (in person as well as virtual).
The on-demand version (recording of the meeting) is not CME accredited.
AMERON Zürich Bellerive au Lac
Utoquai 47
8008 Zürich
Venue website: https://ameroncollection.com/en/zuerich-bellerive-au-lac
ASCO Direct™ is an officially licensed program of the American Society of Clinical Oncology®. ASCO® is a registered trademark of the American Society of Clinical Oncology. All rights reserved. ASCO does not endorse any health care product, therapy, diagnostic test or device.